Parkinson's disease is a progressive neurological disorder caused by the death or damage of certain brain cells, called neurons. It affects the ability to move, control facial expression, and other motor functions. Symptoms of the disease include tremors, muscle rigidity, slow movement, balance problems, and difficulty speaking and swallowing. Other common side effects include depression, cognitive problems, sleep disturbances, and urinary incontinence. Parkinson's disease is caused when certain neurons (nerve cells) in the part of the brain responsible for movement (called the substantia nigra) die or become damaged. These cells are responsible for producing the neurotransmitter dopamine, which helps the brain control movement and coordination. When these cells die or become damaged, it causes a lack of dopamine in the brain, resulting in impaired movement. There is no known cure for Parkinson's disease. However, there are several treatments available that can help to improve the symptoms. Treatment options include medications to increase dopamine levels in the brain, physical therapy to improve mobility and coordination, and surgery to implant deep brain stimulators (DBS) to help manage motor deficits and manage tremors. While there is no known exact cause of Parkinson's disease, there are a few risk factors that can increase a person's chances of developing the disease. Age is believed to play a role, with most people being diagnosed at 50 years or older. Other risk factors include genetics, exposure to environmental toxins, and previous head injuries. While there is no cure for Parkinson's disease, research is being done to find treatments and ways to slow the progression of the disease. Researchers have found that lifestyle and diet modifications can help, as well as finding ways to reduce stress. In addition, new medications and treatments are being developed that could potentially slow the disease and enable people to lead longer, more productive lives.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States